Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.
Deciding when, where, and how quickly to add headcount is rarely straightforward.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.
August brought another wave of leadership changes across biotech, pharma, and research organisations.
When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
Editor's Picks
